One aspect of the present disclosure relates to a functional food composition having a cranial nerve protective effect and a blood flow improvement effect and including antler, an Angelica gigasroot, a Cornus officinalis fruit, a Rehmannia glutinosa root, Lepidium meyenii root powder, a hawthorn fruit, an Astragalus membranaceus root, a cod seed, aloeo wood, a Paeonia lactiflora root, a Cnidium officinale root stem and a Citrus reticulata shell.

A method for preventing or treating overactive bladder includes administering a composition to a subject in need thereof. The composition includes extracts having a Corni Fructus extract, an Angelica gigantis Radix extract, a Lycii Fructus extract, a Cervi parvum cornu extract, a Ginseng Radix Rubra extract, and a Cassiae cortkex extract. The overactive bladder may be a complication of benign prostatic hyperplasia, and the composition may further include an alpha-1A adrenoceptor antagonist. The overactive bladder may be caused by secondary bladder degeneration occurring due to bladder outlet obstruction. The composition may be included in a pharmaceutical composition or a health functional food. The composition also exhibits an excellent effect on overactive bladder that is not relieved even when bladder outlet obstruction disappears by benign prostatic hyperplasia surgical treatment or administration of an alpha-blocker or the like.

A method for preventing or treating overactive bladder includes administering a composition to a subject in need thereof. The composition includes extracts having a Corni Fructus extract, an Angelica gigantis Radix extract, a Lycii Fructus extract, a Cervi parvum cornu extract, a Ginseng Radix Rubra extract, and a Cassiae cortkex extract. The overactive bladder may be a complication of benign prostatic hyperplasia, and the composition may further include an alpha-1A adrenoceptor antagonist. The overactive bladder may be caused by secondary bladder degeneration occurring due to bladder outlet obstruction. The composition may be included in a pharmaceutical composition or a health functional food. The composition also exhibits an excellent effect on overactive bladder that is not relieved even when bladder outlet obstruction disappears by benign prostatic hyperplasia surgical treatment or administration of an alpha-blocker or the like.

A method for preventing or treating overactive bladder includes administering a composition to a subject in need thereof. The composition includes extracts having a Corni Fructus extract, an Angelica gigantis Radix extract, a Lycii Fructus extract, a Cervi parvum cornu extract, a Ginseng Radix Rubra extract, and a Cassiae cortkex extract. The overactive bladder may be a complication of benign prostatic hyperplasia, and the composition may further include an alpha-1A adrenoceptor antagonist. The overactive bladder may be caused by secondary bladder degeneration occurring due to bladder outlet obstruction. The composition may be included in a pharmaceutical composition or a health functional food. The composition also exhibits an excellent effect on overactive bladder that is not relieved even when bladder outlet obstruction disappears by benign prostatic hyperplasia surgical treatment or administration of an alpha-blocker or the like.

Provided is a composition for preventing, alleviating or treating dry eye syndrome, containing an Aucuba japonica extract as an active ingredient. The composition containing an Aucuba japonica extract can be effectively used in the prevention, alleviation or treatment of dry eye syndrome.

A composition for treating fatty liver which comprises extracts of ginseng, Atractylodes rhizome, Crataegus cuneate, Alisma tuber and Cassia obtusifolia L.

A composition for treating fatty liver which comprises extracts of ginseng, Atractylodes rhizome, Crataegus cuneate, Alisma tuber and Cassia obtusifolia L.

An herbal formula used for preparing a pharmaceutical composition for preventing and treating metabolic syndrome is provided. The herbal formula includes Rehmanniae radix preparata, Cornus officinalis, Dioscorea polystachya, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Aconitum carmichaeli, and Cinnamomum cassia.

An herbal formula used for preparing a pharmaceutical composition for preventing and treating metabolic syndrome is provided. The herbal formula includes Rehmanniae radix preparata, Cornus officinalis, Dioscorea polystachya, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Aconitum carmichaeli, and Cinnamomum cassia.

An herbal formula used for preparing a pharmaceutical composition for preventing and treating metabolic syndrome is provided. The herbal formula includes Rehmanniae radix preparata, Cornus officinalis, Dioscorea polystachya, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Aconitum carmichaeli, and Cinnamomum cassia.